. ● . Flora Growth Corp. Applauds Senator Wyden for Introducing the Cannabinoid Safety and Regulations Act September 25, 2024 4:01 PM EDT | Source: Flora Growth Corp. Fort Lauderdale, Florida--(Newsfile Corp. - September 25, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today commended U.S. Senator Ron Wyden for introducing the Cannabinoid Safety and Regulations Act. This landmark piece of legislation is aimed at establishing a comprehensive framework to ensure cannabinoid ...

Core Insights - Clifford Starke, CEO of Flora Growth Corp., has been appointed to the Board of Directors of HoshiCap, a subsidiary of Hoshi International, which operates a cannabis cultivation facility in Portugal [2][4]. Investment and Ownership - Flora Growth Corp. made an initial equity investment of $2.4 million in Hoshi in 2021, acquiring a 10% ownership stake. Hoshi controls 51% of the Portuguese entity managing the cultivation facility [3]. - Approximately $20 million has been invested to construct a state-of-the-art facility in Portugal, which currently employs 18 full-time staff [3]. Strategic Importance - The strategic investment in Hoshi is aimed at gaining access to a low-cost cultivation project to supply the German medical cannabis market, as Portugal is emerging as a leading exporter of cannabis within the European Union [4][6]. - Mr. Starke's extensive experience in global cannabis operations is expected to significantly benefit HoshiCap as it progresses towards obtaining licensure for its cultivation facility [4][5]. Market Outlook - The European cannabis market is anticipated to grow, and HoshiCap is positioned to take advantage of this opportunity. Mr. Starke's appointment is expected to facilitate the establishment of key relationships in a favorable jurisdiction for cannabis cultivation [6].

Core Viewpoint - Clifford Starke has significantly increased his holdings in Flora Growth Corp. through the issuance of stock appreciation rights (SARs), which may indicate a bullish outlook on the company's future performance [2][3]. Group 1: Shareholder Actions - On August 14, 2024, shareholders of Flora Growth Corp. approved the issuance of 1,028,665 SARs to Clifford Starke, along with an additional 575,319 SARs on the same date [2]. - The SARs will vest in 12 equal installments and have a ten-year term, with a post-termination exercise price of one year [2]. Group 2: Ownership Structure - Prior to the acquisition, Starke owned 1,340,056 common shares, representing approximately 10.03% of the outstanding shares of Flora Growth Corp. [3]. - After the acquisition, Starke's holdings increased to 2,944,091 common shares, equating to approximately 16.44% of the outstanding shares on a fully-diluted basis [3]. Group 3: Future Intentions - Starke may acquire additional common shares or other securities of Flora Growth Corp. in the future, depending on market conditions and the company's prospects [4]. - Currently, Starke has no immediate intention to acquire more securities but may adjust his holdings based on evaluations of the company's business and financial condition [6].

● ● . Flora Growth Corp. Appoints Harold Wolkin to Board of Directors; Clifford Starke Named Chairman September 12, 2024 9:20 AM EDT | Source: Flora Growth Corp. Fort Lauderdale, Florida--(Newsfile Corp. - September 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Harold Wolkin as an independent director on its Board of Directors. In this role, Mr. Wolkin will also serve as a member of each of the Company's committees, including a ...

Fort Lauderdale, Florida--(Newsfile Corp. - September 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of its new corporate branding, logo, website, marking an exciting step forward in the company's continued evolution and growth. The new branding initiative reflects the Company's commitment to innovation and its dedication to providing high-quality, premium products. The updated look and feel encapsulate the Company's vision of creating a ...

Core Points - Flora Growth Corp. held its 2024 Annual and Special Meeting of Shareholders, where several proposals were voted on by shareholders [2][5]. Proposal Summaries - **Proposal 1**: Election of four directors to the Board of Directors. The voting results were as follows: - Clifford Starke: 4,969,741 votes for, 97,612 against, 18,969 abstentions, 2,778,760 non-votes - Kevin Taylor: 4,931,118 votes for, 129,648 against, 25,556 abstentions, 2,778,760 non-votes - Edward Woo: 4,881,581 votes for, 179,654 against, 25,087 abstentions, 2,778,760 non-votes - Brendan Cahill: 5,001,476 votes for, 57,680 against, 27,166 abstentions, 2,778,760 non-votes [3][4]. - **Proposal 2**: Reappointment of Davidson & Company LLP as auditors for the fiscal year ending December 31, 2024. The voting results were 7,499,363 votes for, 323,623 against, and 42,096 abstentions [4]. - **Proposal 3**: Approval of an amendment to the Company's 2022 Incentive Compensation Plan to increase the number of shares from 950,000 to 2,500,000. The voting results were 4,776,425 votes for, 285,446 against, and 24,451 abstentions [4]. - **Proposal 4**: Approval of the grant of stock appreciation rights to the CEO and CFO. The voting results were 4,802,189 votes for, 253,288 against, and 30,845 abstentions [4]. - **Proposal 5**: Approval of the issuance of 635,363 shares to acquire the minority interest of TruHC Pharma GmbH. The voting results were 4,249,883 votes for, 184,837 against, and 26,704 abstentions [5]. Company Overview - Flora Growth Corp. is a leader in consumer-packaged goods and pharmaceutical distribution, serving all 50 states and 28 countries with over 20,000 points of distribution globally [6].

Fort Lauderdale, Florida--(Newsfile Corp. - August 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the three and six months ended June 30, 2024. "In the second quarter of 2024, we at Flora, demonstrated an aptitude to make accretive acquisitions and form strategic partnerships to capitalize on the most robust market trends. In Germany, we acquired TruHC Pharma GmbH in response to the de-scheduling of cannabis, the re ...

Fort Lauderdale, Florida--(Newsfile Corp. - August 8, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") proudly celebrates National CBD Day, a day dedicated to recognizing the vast benefits and rapid growth of the CBD industry in the United States and beyond. National CBD Day not only celebrates the therapeutic benefits of cannabidiol ("CBD") but also serves as a reminder of the political strides made in recent years. Legislative bodies across various states have increasingly ...

Core Insights - Flora Growth Corp. has launched two new products under its JustCBD brand: JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies, aimed at stress management and sleep enhancement [3][5]. Product Details - The JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies are formulated with Gaba and L-Theanine, known for their calming effects, to help users manage stress and achieve relaxation [4]. - The JustCBD+ Sleep Magnesium & Melatonin Raspberry Gummies combine Magnesium and Melatonin to assist users in falling asleep faster and experiencing deeper sleep, with raspberry flavor enhancing the bedtime routine [5]. Company Overview - JustCBD is recognized for high-quality CBD products sourced from organically grown hemp in the USA, offering a wide range of items including gummies, oils, and creams, and has received over 22,000 five-star reviews [6]. - Flora Growth Corp. operates as a leader in consumer-packaged goods and pharmaceutical distribution, serving all 50 states and 28 countries with over 20,000 distribution points globally [7].

Core Insights - Flora Growth Corp. has entered into a share purchase agreement to acquire Australian Vaporizers Pty Limited for 550,000 common shares valued at $0.7 million, with the transaction closing on June 4, 2024 [1] Company Overview - Australian Vaporizers, founded in 2010, is one of the largest online retailers of vaporizers and accessories in Australia, specializing in dry herb vaporizers and serving over 30,000 active customers [2] - The company has sold over 92,000 units through both business-to-business and direct-to-consumer channels [2] Strategic Implications - The acquisition is expected to improve Flora's bottom line and create synergies with its existing portfolio, particularly by selling Vessel Brand products in Australia, which is noted as Flora's fastest-growing segment [3]